U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
TAB-08
Preferred Name English
TGN-1412
Common Name English
TGN1412
Common Name English
Theralizumab [WHO-DD]
Common Name English
THERALIZUMAB
Common Name English
TAB08
Common Name English
Code System Code Type Description
CAS
906068-56-2
Created by admin on Tue Apr 01 20:41:03 GMT 2025 , Edited by admin on Tue Apr 01 20:41:03 GMT 2025
PRIMARY
WIKIPEDIA
Theralizumab
Created by admin on Tue Apr 01 20:41:03 GMT 2025 , Edited by admin on Tue Apr 01 20:41:03 GMT 2025
PRIMARY
FDA UNII
POO0DOD3AS
Created by admin on Tue Apr 01 20:41:03 GMT 2025 , Edited by admin on Tue Apr 01 20:41:03 GMT 2025
PRIMARY
SMS_ID
100000178120
Created by admin on Tue Apr 01 20:41:03 GMT 2025 , Edited by admin on Tue Apr 01 20:41:03 GMT 2025
PRIMARY
ACTIVE MOIETY
TGN-1412
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966